TERRAFORMATION
21.9.2022 15:09:38 CEST | Business Wire | Press release
Terraformation, the world’s first global forest carbon accelerator, today announces the launch of the Seed to Forest Alliance, with American Forests, Ecosystem Restoration Camps and One Tree Planted as founding members, as well as 1t.org US as an advisory partner.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220915005905/en/
Estimated Number of seed banks still needed per country based on low, medium and high “need for seeds scenarios". Source: Terraformation
Launching at Climate Week NYC 2022, the Alliance supports biodiverse, native reforestation by providing a network to connect forestry teams with financial and technical support; members, who will include corporates, NGOs, and philanthropists, will contribute to research and thought leadership to accelerate reforestation, and share results, best practices and expertise to help the reforestation movement overcome the largest bottlenecks to scale.
The Alliance will initially focus on inadequate seed supply as a barrier to reforestation at scale. New research published today by Terraformation sheds light on the significant scale of upgrades required in the world’s existing seed banking infrastructure to meet global restoration goals.
In recent years, global companies have committed to planting over 3.6 billion trees in their sustainability plans. At COP26, $7.2 billion of private investment was committed to protect and restore forests. However, these targets are not achievable without investment and innovation in global seed banking infrastructure.
Yishan Wong, founder and CEO of Terraformation, said: “Lasting climate solutions only come from collective action across diverse stakeholders. We’re incredibly excited to be working with organizations with the expertise, influence and determination to have a real impact on reforestation around the world. Native ecosystem restoration — with the right plants in the right places — is the most effective and immediately scalable carbon capture solution. Together, we can restore the future of our planet by conserving one of our most valuable resources at the heart of restoration: the seeds.”
Kevin O’Hara, Lead of 1t.org US at American Forests, added: “Time and time again we hear the real and immediate challenges in finding the seeds necessary to reach our ambitious national reforestation goals. 1t.org US is proud to support the work the Seed to Forest Alliance will do to help lift up public, private and NGO efforts to ramp up seed supply here in the US and around the world.”
New research reveals urgency for global seed bank network
Against this backdrop, Terraformation has published The Global Seed Bank Index, the first global review of seed banking infrastructure. The report analyzed the number of seed banks needed to meet the “global restoration potential,” defined as the area of land in the world available for ecological restoration.
The research found that a global decentralized seed bank network would drastically improve restoration outcomes, preserve threatened species, and benefit local communities.
Key findings include:
- Currently, 410 seed banks store native species for ecosystem restoration across 96 countries, but more are needed in almost all countries. Establishing larger regional seed banks could help meet the need for seeds more efficiently.
- More than half of the world’s countries have no known seed banks.
- While the United States, Australia, Brazil and China have the most seed banks, they also need the most new seed banks to meet their restoration potential within 10 years.
- The restoration movement will also need to train hundreds of thousands of new seed collectors to preserve and restore threatened biodiversity.
- The tropics and biodiversity hotspots are the highest priority locations for additional seed banking capacity given their high impact on biodiversity and climate regulation.
Following the study, Terraformation is calling on:
- Businesses to invest in seed banks in their sustainability plans: seed banks are a tangible restoration solution that directly support the UN’s Sustainable Development Goals.
- Governments to support seed banks as a natural resource management strategy: government support at any level can help create a well-connected and scalable decentralized network with locally adapted, resilient seeds.
- Local restoration organizations to prioritize seed banking: people already doing restoration on the ground can add seed banking to their restoration toolkits and scale their work with higher efficiency.
Seed to Forest Alliance
Terraformation and its Alliance members are committed to scaling solutions to the largest bottlenecks to native forest restoration. Four of the largest bottlenecks are inadequate seed supplies, a lack of on-the-ground technical expertise, data accessibility, and insufficient financing. The Alliance will first focus on seed supply, connecting forestry groups with the funding, technology and training to establish local seed supplies and enable biodiverse reforestation at scale.
The Alliance is underpinned by three guiding principles:
- Biodiversity and ecological resilience: the Alliance will only support native, biodiverse forest restoration in accordance with the IUCN Global Standard for Nature-based Solutions. It does not support monocultures or destructive forestry practices.
- Community: the Alliance believes communities are at the heart of resilient and just land restoration. It supports forest restoration projects in alignment with UN Sustainable Development Goals, especially with regard to gender equality, decent work, human health and well-being, and elimination of poverty.
- Measurable impact and transparency: the Alliance prioritizes impact, and as such will set quantifiable goals and transparently report progress.
The Global Seed Bank Index is available to download here.
- ENDS -
About Terraformation
Terraformation is dedicated to restoring the world's forests to stabilize our climate, revive ecosystems, and build thriving communities.
It is launching a forest carbon accelerator, supporting early-stage forestry teams to launch, build, and scale biodiverse reforestation projects and produce high-quality, verified carbon credits.
Terraformation’s partner network spans five continents and includes diverse landowners and organizations. It was founded in 2019 by Yishan Wong, former CEO of Reddit.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220915005905/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 12:38:00 CEST | Press release
For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will
Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital18.9.2026 11:48:00 CEST | Press release
Estithmar Holding Q.P.S.C. announced the completion of the transfer of a 48.68% stake in Shahba Bank to Masaref Holding LLC, subsidiary of Estithmar Capital, Estithmar Holding’s financial services and investments arm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918807909/en/ Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital (Photo: AETOSWire) As a shareholder, Masaref Holding intends to support the assessment of proposals aimed at strengthening Shahba Bank’s financial, operational and technological capabilities, including potential capital enhancement, branch network expansion, and the development of products and services for individuals, businesses and SMEs. The proposals may include modernizing banking and operational systems, develop digital services, and strengthen governance, compliance, risk management and cybersecurity to enhance
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
